Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases

被引:6
|
作者
Beaumet, Morane [1 ]
Lazinski, Leticia M. [1 ]
Maresca, Marc [2 ]
Haudecoeur, Romain [1 ]
机构
[1] Univ Grenoble Alpes, CNRS 5063, DPM, F-38000 Grenoble, France
[2] Aix Marseille Univ, CNRS, Cent Marseille, iSm2, Marseille, France
关键词
Tyrosinase inhibitor; Melanin; Transition-state analogue; Skin-whitening agents; Catechol-mimicking; Non-oxidizable; KOJIC ACID ANALOGS; MUSHROOM TYROSINASE; HYDROXYPYRIDINONE DERIVATIVES; KINETIC CHARACTERIZATION; BACTERIAL TYROSINASES; BIOLOGICAL EVALUATION; MODEL COMPLEXES; BINDING; AURONES; MELANOGENESIS;
D O I
10.1016/j.ejmech.2023.115672
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tyrosinases are copper-containing metalloenzymes involved in several processes in both mammals, insects, bacteria, fungi and plants. Their phenol oxidation properties are especially responsible for human melanogenesis, potentially leading to abnormal pigmentation, and for postharvest vegetable tissue browning. Thus, targeting tyrosinases attracts interest for applications both in dermocosmetic and agrofood fields. However, a large part of the literature about tyrosinase inhibitors is dedicated to the report of copper-interacting phenolic compounds, that are more likely alternative substrates leading to undesirable toxic quinones production. To circumvent this issue, the use of catechol-mimicking copper-chelating groups that are analogues of the tyrosinase oxidation transition state appears as a valuable strategy. Relying on several non-oxidizable pyridinone, pyrone or tropolone moieties, innovative inhibitors were developed, especially within the past decade, and the best reported ana-logues reached IC50 values in the nanomolar range. Herein, we review the design, the activity against several tyrosinases, and the proposed binding modes of reported catechol-mimicking, non-oxidizable molecules, in light of recent structural data.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Peptidic transition state analogues as PRMT inhibitors
    Zhang, Yurui
    van Haren, Matthijs J.
    Martin, Nathaniel, I
    METHODS, 2020, 175 : 24 - 29
  • [32] ENZYME-INHIBITORS - GROUND-STATE TRANSITION-STATE ANALOGS
    ABELES, RH
    DRUG DEVELOPMENT RESEARCH, 1987, 10 (04) : 221 - 234
  • [33] Syntheses of transition-state analogues for mechanistic studies of organocatalytic desymmetrization reactions
    Leahy, Clare
    Alberg, David
    Hofmeister, Gretchen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [34] Four generations of transition-state analogues for human purine nucleoside phosphorylase
    Ho, Meng-Chiao
    Shi, Wuxian
    Rinaldo-Matthis, Agnes
    Tyler, Peter C.
    Evans, Gary B.
    Clinch, Keith
    Almo, Steven C.
    Schramm, Vern L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (11) : 4805 - 4812
  • [35] Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin
    Lillelund, VH
    Jensen, HH
    Liang, XF
    Bols, M
    CHEMICAL REVIEWS, 2002, 102 (02) : 515 - 553
  • [36] DESIGN OF TRANSITION-STATE ANALOG INHIBITORS FOR GABA-TRANSAMINASE
    WINKLER, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1982, 184 (SEP): : 81 - PHYS
  • [37] TRANSITION-STATE AND MECHANISM-BASED INHIBITORS FOR CYSTEINE PROTEASES
    POWERS, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 240 - MEDI
  • [38] Transition-state analogue inhibitors of γ-secretase block presenilin processing
    Bakshi, P
    Campbell, WA
    Xia, WM
    Wolfe, MS
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S208 - S208
  • [39] Bivalent transition-state analogue inhibitors of human glyoxalase I
    Zheng, ZB
    Creighton, DJ
    ORGANIC LETTERS, 2003, 5 (25) : 4855 - 4858
  • [40] NEW TRANSITION-STATE ANALOG INHIBITORS OF ASPARTATE-TRANSCARBAMYLASE
    WEDLER, FC
    FARRINGTON, GK
    BIOCHEMISTRY, 1984, 23 (14) : 3352 - 3352